Journal
CELL
Volume 153, Issue 1, Pages 17-37Publisher
CELL PRESS
DOI: 10.1016/j.cell.2013.03.002
Keywords
-
Categories
Funding
- U.S. National Human Genome Research Institute
- U.S. National Cancer Institute
- Slim Initiative for Genomic Medicine
- Broad Institute
- Department of Defense
- Starr Cancer Consortium
- Prostate Cancer Foundation
- Melanoma Research Alliance
- Adelson Medical Research Foundation
Ask authors/readers for more resources
Systematic studies of the cancer genome have exploded in recent years. These studies have revealed scores of new cancer genes, including many in processes not previously known to be causal targets in cancer. The genes affect cell signaling, chromatin, and epigenomic regulation; RNA splicing; protein homeostasis; metabolism; and lineage maturation. Still, cancer genomics is in its infancy. Much work remains to complete the mutational catalog in primary tumors and across the natural history of cancer, to connect recurrent genomic alterations to altered pathways and acquired cellular vulnerabilities, and to use this information to guide the development and application of therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available